OCTP.L Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (5 birž. 2024 @ 18:28):
Our systems believe the stock currently is undervalued by 0.06% compare to its pairs and should correct upwards.

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines...

Stats
Dzisiejszy wolumen	7.83M
Średni wolumen	14.97M
Kapitalizacja rynkowa	1.25M
EPS	£-0.00210 ( Q2 \| 2023-10-31 )
Następna data zysków	( £0 ) 2024-09-27
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.110 (Sector) 464.83 (Industry) 174.55
ATR14	£0.00700 (6.09%)

4BB.L -0.97%

APTA.L 3.06%

AREC.L -4.17%

CIZ.L 5.88%

OBI.L -2.52%

OCTP.L -4.17%

ONT.L 2.12%

POLB.L 1.54%

ROQ.L -5.26%

Korelacja (AI algo v.1.1b): Undervalued: 0.06% £0.115 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: 0.02 (neutral)

Krótki: 0.48 (neutral)

Signal:(40.947) Neutral

Oxford Cannabinoid Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oxford Cannabinoid Korelacja - Waluta/Towar

0.12
( neutral )

0.24
( neutral )

0.00
( neutral )

-0.19
( neutral )

Oxford Cannabinoid Finanse

Annual	2022
Przychody:	£0
Zysk brutto:	£-38 808.00 (0.00 %)
EPS:	£-0.00620

FY	2022
Przychody:	£0
Zysk brutto:	£-38 808.00 (0.00 %)
EPS:	£-0.00620

FY	2021
Przychody:	£0.00
Zysk brutto:	£-445 400 (0.00 %)
EPS:	£-0.00336

FY	2020
Przychody:	£0.00
Zysk brutto:	£-1.24M (0.00 %)
EPS:	£-0.00223

Financial Reports:

No articles found.

Oxford Cannabinoid Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Oxford Cannabinoid

Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate is OCT461201, a selective CB2 receptor agonist in solid oral dosage form that is in pre-clinical development for use in the treatment of IBS-associated visceral pain, as well as neuropathic pain conditions, including post herpetic neuralgia. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.